Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by Jon9800

V.HEM

$HEM grants worldwide field license to PreCerv Inc.

Hemostemix recently granted the global field license of use of NCP-01 and its...

June 28, 2022

V.HEM

Data audit efficiently executed, results came out to be auth

Hemostemix have been handed back its intellectual property consisting of all...

June 28, 2022

V.HEM

$HEM grants worldwide field license to PreCerv Inc.

Hemostemix recently granted the global field license of use of NCP-01 and its...

June 27, 2022

V.HEM

$HEM on recent prolific stock run on the TSX-V index

$HEM observed a major bound on the TSX-V that left the entire market at shock...

June 27, 2022

V.HEM

$HEM expansion of the common share and warrant within the of

The recently announced private placement of 15 million units, in which each...

June 27, 2022

V.HEM

Existing shareholder exemption of the Hemostemix offer

The offering constituting the private non-brokered placement of 15 Million...

June 27, 2022

V.HEM

$HEM reports non-brokered private placement of 15 million un

Hemostemix disclosed a non-brokered private offering of about 15 million...

June 24, 2022

V.HEM

$HMTXF common share and warrant elaboration

The recently announced private placement of 15 million units has put the...

June 24, 2022

V.HEM

$HMTXF announced closure of the first tranche of the unit pr

$HMTXF have successfully closed the first tranche of the announced on May 29....

June 24, 2022

V.HEM

$HMTXF get backs all its intellectual property

Hemostemix is now in possession of all of its intellectual property...

June 24, 2022

V.HEM

Hemostemix owns over 91 patents

The Company owns 91 patents across five patent families titled: Regulating...

June 23, 2022

V.HEM

Hemostemix informs regarding non-brokered private placement

Hemostemix Inc. announces a non-brokered private placement of up to 15...

June 23, 2022

V.HEM

The approval of offering by TSX-V

The offering is subject to all the necessary regulatory approvals including...

June 23, 2022

V.HEM

Hemostemix Announces the Incorporation of PreCerv Inc.

$HEM has announced it has incorporated PreCerv Inc. as a wholly owned...

June 23, 2022

V.HEM

Hemostemix reclaims possession of all its lost intellectual

All the intellectual data including all phase 2 clinical trial data, all the...

June 23, 2022

V.HEM

Hemostemix regains legal possession of all its missing intel

All the intellectual data including all phase 2 clinical trial data, all the...

June 23, 2022

V.HEM

$HMTXF rendering investors staggered with profit on the OTC

HMTXF today marked a rather gallant opening on the OTC market, and is...

June 22, 2022

V.HEM

Treating efficiency of NCP-01 a revolutionary invention by H

Neuropathic pain syndromes can be treated with NCP-01 and its autologous stem...

June 22, 2022

V.HEM

Hemostemix – company outlook & stock Insights

Hemostemix Inc. (TSX-V: $HEM) is a publicly-traded biotech company. Its...

June 22, 2022

V.HEM

Hemostemix medication plan for cardiac arrest

The company, one of the leading products, ACPs delivered via injection...

June 22, 2022

Prev 1 2 3 4 5 Next

Featured Company

SEGO Resources Inc

SEGO Resources Inc V.SGZ

SEGO Resources Inc. is a Canada-based exploration stage company. The Company is engaged in the acquisition, exploration, and ... view more »